Impel Pharmaceuticals Inc Stock (OTC: IMPL)

Impel Pharmaceuticals Inc Stock (OTC:IMPL), Trade Ideas

Impel Pharmaceuticals

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATNF

ATXI

AULT

BDRX

BMEA

ESGL

FLNC

HNRA

IMPL

LESL

OKTA

RDHL

SEEL

SMFL

VERV

WDAY

YOSH

Shares of  Workday, Inc. (NASDAQ: WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter.

Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Earnings

Eurozone

Commodities

Global

Intraday Update

BGLC

PRQR

SHOP

THAR

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday.

Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13% to 14,231.78. The S&amp;P 500 also fell, dropping, 0.25% to 4,548.14.

US Stocks Lower; Dow Falls Over 50 Points

AGRI

APLM

BPTH

CAPT

CMND

CNEY

CRKN

CUEN

HKIT

Intelligent Bio Solutions Inc. - Common Stock

INBS

MOBQ

MVLA

TIGR

TRVN

Shares of  UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Impel Pharmaceuticals Inc

Implanet SA

IMPLENIA AG DIETLIKON by Implenia Ag, Dietlikon

Implenia AG

Former President Donald Trump&#8217;s close allies, including Boris Epshteyn, Mark Meadows, and Rudy Giuliani, have been indicted by an Arizona grand jury. The indictment pertains to their alleged involvement in attempts to overturn the 2020 election results.
What Happened: The Arizona grand jury handed down an indictment against several individuals associated with Trump&#8217;s 2020 campaign. These individuals stand accused of trying to subvert the election results, including the fraudulent electors from Arizona, <a href="https://edition.cnn.com/2024/04/24/politics/arizona-criminal-charges-2020-election-subversion/index.html">reported</a> CNN on Wednesday.
Among the indicted are Epshteyn, a former White House aide and one of Trump&#8217;s closest advisers, former White House chief of staff Meadows, and former New York Mayor Giuliani, as per a source familiar with the investigation, according to CNN .
See Also: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive An Additional $1.26B In DJT Shares: Key Milestone Ahead (UPDATED)</a>
Arizona Attorney General Kris Mayes announced the indictment on Wednesday night, focusing on the 11 individuals who acted as pro-Trump electors in the state. The names of several other indicted defendants remain redacted until they have been served, Mayes stated.
While Trump himself has not been charged in Arizona, the indictment details suggest he is referred to as &#8220;Unindicted Coconspirator 1&#8221;.
Why It Matters: The indictment of Trump&#8217;s allies in Arizona marks a significant development in the ongoing legal battles surrounding the 2020 election. 
In an interview with Fox News in August 2023, Rep. Marjorie Taylor Greene (R-Ga), a staunch Trump supporter, suggested that the ex-president could potentially <a href="https://www.benzinga.com/news/23/08/33956035/marjorie-taylor-greene-says-donald-trump-may-face-fifth-indictment-in-arizona?itm_source=parsely-api">face a fifth indictment</a>, this time in Arizona, based on a similar alleged fraudulent elector scheme aimed at undermining President Joe Biden&#8217;s narrow victory in the state. 
Image made using photos on Shutterstock
Read Next: <a href="https://www.benzinga.com/news/24/04/38349699/marjorie-taylor-greene-says-mike-johnsons-speakership-is-over-after-house-passes-ukraine-aid-package?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Says Mike Johnson&#8217;s Speakership Is &#8216;Over&#8217; After House Passes Ukraine Aid Package: &#8216;Resign And Allow Us To Move Forward&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Politics

General

Trump Allies Giuliani, Meadows Indicted By Arizona Grand Jury For Alleged 2020 Election Subversion — Ex-President Possibly 'Unindicted Co-conspirator 1': Report

APDN

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

WNBA star Brittney Griner is sharing her story for the first time about spending 10 months in a Russian prison in a special edition of 20/20.
In a clip of the emotional interview, Griner shared her experience of having been <a href="https://www.benzinga.com/markets/cannabis/22/03/26007231/breaking-russia-detains-wnba-all-star-brittney-griner-for-alleged-possession-of-hash-oil">arrested and incarcerated</a> after a small amount of cannabis oil was found in her suitcase at a Moscow airport. At the time, Feb. 17, 2022 — just one week before Russia invaded Ukraine — Griner was heading back to Russia where she played for seven years during the off-season from her U.S. team, a center for the Phoenix Mercury.
"I was just so scared for everything because there&#8217;s so much unknown," Griner <a href="https://abcnews.go.com/US/wnba-star-brittney-griner-opens-harrowing-russian-detention/story?id=109495984">told</a> ABC's&nbsp;Robin Roberts,&nbsp;co-anchor of&nbsp;Good Morning America.
Roberts asked Griner what was going on in her mind when she realized that the cannabis cartridges were found in her luggage. Griner, a medical marijuana patient in the U.S., said she realized immediately that her mistake could have devastating consequences.
"My life is over right here," Griner answered. 
Griner admitted that the conditions were so terrible that she had thoughts of ending her life. "The mattress had a huge blood stain on it. I had no soap, no toilet paper. That was the moment where I just felt less than a human," she told Roberts. "I just didn&#8217;t think I could get through what I needed to get through.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="1st look at Brittney Griner&#039;s interview" width="500" height="281" src="https://www.youtube.com/embed/ovmtrgsjwYA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
When Griner <a href="https://www.benzinga.com/markets/cannabis/22/07/27987966/breaking-brittney-griner-pleads-guilty-biden-lashes-out-over-her-detention-russia-calls-it-hype-">pleaded guilty to drug charges</a> in July 2022, she told a judge in Moscow that she accidentally packed the vape cartridges in her luggage and did not intentionally break Russian law. 
Sentenced to <a href="https://www.benzinga.com/markets/cannabis/22/08/28355539/closing-remarks-in-brittney-griner-case-verdict-and-sentencing-expected-soon">nine years in prison</a> in August, Griner was released on Dec. 8 in a prisoner swap for Russian arms dealer&nbsp;Viktor Bout. But not before being moved to a <a href="https://www.benzinga.com/markets/cannabis/22/11/29642858/brittney-griner-being-moved-to-russian-penal-colony-her-lawyers-dont-yet-know-exact-location">notorious penal colony</a>.
In addition to the exclusive interview, Griner&#8217;s <a href="https://www.benzinga.com/markets/cannabis/23/12/36147628/brittney-griner-will-exclusively-share-her-story-across-multiple-platforms-via-espn-disney-partn">story is the subject of an ESPN documentary</a> and a potential scripted series with ABC detailing her experience.
Photo: Courtesy of ESPN press room

Cannabis

Entertainment

Sports

Media

Brittney Griner Talks For The First Time About Her Russian Detention In Exclusive '20/20' Special

For the first time in more than 130 years, voters will likely choose between two candidates with presidential experience for the <a href="https://www.benzinga.com/topic/2024-election">2024 presidential election.</a>
Here's a look at who voters in swing states currently favor in a 2020 election rematch of Donald Trump and Joe Biden.
What Happened: A close race is expected between Biden and Trump in the 2024 election based on election polls <a href="https://www.benzinga.com/general/sports-betting/24/04/38417836/trump-and-biden-get-ready-2024-election-betting-odds-point-to-major-showdown">and betting odds.</a>
Key demographics like young voters and old voters could play an important role in the election, along with <a href="https://www.benzinga.com/topic/swing-states">key swing states.</a>
A new poll of voters in swing states shows Biden gaining ground over Trump, who has led the way in these key states in recent months.
Here are the results of the recent swing state <a href="https://pro.morningconsult.com/analysis/swing-state-polling-april-2024">poll </a>from Morning Consult for the month of April, with the results from March in parentheses.
Arizona: 49% Trump (48%), 42% Biden (43%)
Georgia: 49% Trump (49%), 43% Biden (42%)
Michigan: 47% Biden (45%), 45% Trump (45%)
Nevada: 51% Trump (46%), 43% Biden (44%)
North Carolina: 51% Trump (49%), 41% Biden (43%)
Pennsylvania: 47% Trump (45%), 46% Biden (45%)
Wisconsin: 48% Trump (45%), 44% Biden (46%)
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38358680/can-biden-or-trump-build-ikea-furniture-2024-election-polls-may-have-gone-too-far">Can Biden Or Trump Build IKEA Furniture? 2024 Election Polls May Have Gone Too Far</a>
Why It's Important: The new poll shows Trump gaining support in Arizona, Nevada, North Carolina, Pennsylvania and Wisconsin. Trump has some of his biggest leads in Arizona, Nevada and North Carolina since polling began in October 2023 for the swing states.
Biden gained support in Georgia, Michigan and Pennsylvania, but lost support in several states. The key win for the current president is taking a lead in Michigan for the first time since polling began in October.
The new poll also showed Biden gaining voter trust on several items including Medicare and Social Security.
The <a href="https://www.benzinga.com/general/politics/24/03/37884006/trump-vs-biden-key-swing-states-arizona-nevada-michigan-wisconsin-show-close-races-heres-the-rol">seven swing states </a>together represent 93 electoral votes in the 2024 election. Six of the seven swing states were won by Biden in the 2020 election, with Trump winning North Carolina. Five of the seven swing states won by Biden in 2020 flipped from Trump to Biden in the election, including Arizona, Michigan and Wisconsin.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38366379/trump-committed-conspiracy-to-undermine-the-integrity-of-a-presidential-election-prosecution-all">Trump Committed &#8216;Conspiracy To Undermine The Integrity Of A Presidential Election,&#8217; Prosecution Alleges In Hush Money Trial</a>
Photo: Shutterstock

Trump Vs. Biden: Former President Dominates Swing States, But Loses One For First Time In New 2024 Election Poll

If you're the parent of a child under 12 and have streaming platform Disney+, there's a good chance you've watched Australian <a href="https://www.benzinga.com/general/entertainment/23/12/36400565/is-disneys-percy-jackson-reboot-a-streaming-sensation-the-impact-of-new-shows-and-blueys-tr">animated hit &#8220;Bluey.</a>&#8220;
The show is turning in big numbers for Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), but the company also hinted at the show ending or having less content going forward.
What Happened: Streaming platform Disney+, part of the Walt Disney Company, has one of the<a href="https://www.benzinga.com/general/entertainment/24/04/38024244/appletv-a-streaming-winner-new-survey-shows-platform-has-smallest-library-highest-rated-con"> largest content libraries</a> of family-based content, which is a draw to getting adults with children to subscribe to the platform.
Among the hit shows on Disney+ is the Australian show "Bluey," with Disney having the rights in the U.S. The show has drawn praise from kids and from parents, thanks to its relatable storylines.
On April 14, Disney+ aired the episode "The Sign" from the third season of the show. At 28 minutes, the episode was around three times longer than most episodes.
The episode had 10.4 million views globally in its first week on Disney+, <a href="https://www.hollywoodreporter.com/tv/tv-news/bluey-the-sign-ratings-disney-plus-1235879242/">according </a>to The Hollywood Reporter. This ranked as the most-watched episode in the show's history and had the biggest viewership for a Disney Junior show on Disney+.
This episode and its predecessor "Ghostbasket" left fans asking questions about the future as the Heeler family featured on "Bluey" dealt with a potential sale of their home and a move to another city.
Fans were treated to a surprise with the season 3 finale episode appropriately titled, "Surprise."
The episode included a flash forward to main character Bluey as an adult and with a child —&nbsp;leaving more questions about if the show is ending, as many voiced on social media that it felt more like a series finale than a season finale.
Related Link:<a href="https://www.benzinga.com/news/earnings/24/02/36993564/disney-invests-1-5b-in-fortnite-owner-epic-games-in-biggest-ever-gaming-entry-posts-q1-earnings-bea"> Disney Invests $1.5B In Fortnite Owner Epic Games In &#8216;Biggest Ever&#8217; Gaming Entry, Posts Q1 Earnings Beat, Revenue Miss</a>
What's Next: Show creator Joe Brumm told The Hollywood Reporter in 2023 that the BBC, which originally commissioned the show alongside Australia's ABC, to not talk about the kids' voices or the future of the show.&nbsp;
Brumm has also said he's taking a break after the third season, which added to the speculation about the show's future.&nbsp;
A producer of "Bluey" recently confirmed to <a href="https://www.bbc.com/news/entertainment-arts-68795941">BBC </a>that the show will return in the future. Another producer also said it would be a "dream" to make a movie based on Bluey and her family in the future.
"Bluey" debuted on the streaming platform in 2020, becoming one of the most-watched shows in the U.S. on streaming platforms. Data from Nielsen showed the series had an average of 1.19 billion minutes viewed per week across a three-season library of 150 episodes.
The children's show is the most streamed show in the U.S. in 2024 based on viewing time tracked by Nielsen. The show ranked second in 2023 and sixth in 2022.
The show has been a huge hit for Disney and a gap between seasons or an end to the show could eliminate one of the key pieces of content.&nbsp;
In a highly competitive streaming market, platforms need shows like "Bluey" that aren't available other places and are must-watch content for at least one age demographic.
With its appeal to kids and parents alike, "Bluey" hits multiple demographics.
Read Next: <a href="https://www.benzinga.com/general/entertainment/24/03/37701205/taylor-swift-concert-film-hits-streaming-heres-how-to-watch-the-eras-tour-taylors-version">Taylor Swift Concert Film Hits Streaming: Here&#8217;s How To Watch &#8216;The Eras Tour (Taylor&#8217;s Version)&#8217;</a>
Photo: Courtesy Disney+ UK

Bluey Dominates Ratings For Disney+: Kids, Parents Hoping Hit Show Not Over

<h1 class="wp-block-heading">Top Stories for April 24, 2024:</h1>
<ol>
<li>American Battery Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>) updated <a href="https://www.benzinga.com/news/24/04/38404516/american-battery-technology-company-publishes-updated-initial-assessment-and-economic-analysis-for-t">its initial assessment</a> for the Tonopah Flats Lithium Project (TFLP).</li>
</ol>
It refined the project&#8217;s scope to use only measured and indicated mineral resources, excluding the more speculative inferred resources.&nbsp;
This strategy improves the project's economics by enhancing access to higher-quality resources and optimizing processing at its newly built demonstration facility. 
Key updates include a 7% reduction in total processed claystone, an 8% increase in lithium grade, a 7% decrease in production costs and a 6% rise in the project&#8217;s net present value to $4.67 billion.
<ol start="2">
<li>Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) reported first-quarter results, with net sales of $4.7 billion and net income of $584 million. </li>
</ol>
Highlights include 3.3 million tons of steel shipments, operating income of $751 million and adjusted EBITDA of $879 million.&nbsp;
The company&#8217;s financial health was further supported by liquidity of $3.1 billion and shareholder returns through $298 million in stock repurchases and an 8% dividend increase.&nbsp;
Demand was solid across sectors, particularly automotive and construction, driving sequential improvements in earnings and operational performance.
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/news/24/04/38390383/copper-prices-approach-2-year-highs-whats-behind-analysts-12-000-price-prediction-for-2026">Copper Prices Approach 2-Year Highs: What&#8217;s Behind Analyst&#8217;s $12,000 Price Prediction For 2026?</a>
<ol start="3">
<li>Gold Royalty Corp (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) entered into a three-year mutual cooperation agreement with Taurus Mining Royalty Fund that allows both parties to co-invest in precious metals royalties and streams. </li>
</ol>
The agreement focuses on assets valued at $30 million or more and provides a framework for identifying and evaluating co-investment opportunities, with the option for each party to invest 25% to 50% in selected transactions.&nbsp;
Additionally, any future sales of interests acquired through this partnership will offer first rights to the other partner.
<ol start="4">
<li>Coeur Mining Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) released its 2023 ESG Report, emphasizing its progress in environmental, social and governance efforts aligned with shareholder value. </li>
</ol>
The report highlights Coeur&#8217;s achievement of the lowest injury rate among peers at 0.46 and its adoption of the Global Industry Standard on Tailings Management (placing it among the top 17% of non-International Council on Mining and Metals companies).
The company also shared its commitment to biodiversity through the Biodiversity Management Standard and advancements in climate resilience, aiming for a 35% reduction in GHG emissions by the end of 2024.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/m-a/24/04/38405991/equinox-gold-snaps-up-greenstone-gold-mines-for-995m-in-incredibly-rare-deal">Equinox Gold Snaps Up Greenstone Gold Mines For $995 Million In &#8216;Incredibly Rare&#8217; Deal</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo: Jose Luis Stephens via Shutterstock.

ABAT

GROY

STLD

American Battery Optimizes Lithium Project; Steel Dynamics Reports Q1 Results; Gold Royalty Teams Up With Taurus Mining And More: Wednesday's Top Mining Stories

Helix Energy Solns Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.02 by 250 percent. The company reported quarterly sales of $296.211 million which missed the analyst consensus estimate of $296.725 million by 0.17 percent. This is a 18.44 percent increase over sales of $250.084 million the same period last year.

Earnings Misses

Helix Energy Solns Gr Q1 2024 Adj EPS $(0.03) Misses $0.02 Estimate, Sales $296.211M Miss $296.725M Estimate

National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.76 by 7.89 percent. This is a 22.64 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $101.724 million which missed the analyst consensus estimate of $103.683 million by 1.89 percent. This is a 7.15 percent decrease over sales of $109.554 million the same period last year.

Earnings Beats

NBHC

National Bank Holdings Q1 2024 GAAP EPS $0.82 Beats $0.76 Estimate, Sales $101.724M Miss $103.683M Estimate

In June 2022, New York Gov. Kathy Hochul announced a deal had finally been reached to <a href="https://www.benzinga.com/markets/cannabis/22/01/24932856/new-york-gov-kathy-hochul-pledges-200m-to-boost-social-equity-efforts-as-part-of-cannabis-legali">fund a $200 million public-private effort</a>, which would finance cannabis dispensaries run by the people who have been the most impacted by the war on drugs.
The much-anticipated public-private fund is now coming under scrutiny following an <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">investigation</a> by THE CITY&#8217;s Rosalind Adams, which uncovered a "lopsided deal" favoring the private equity firm Chicago Atlantic Group and raising concerns about the state's social equity goals. 
The agreement heavily favors Chicago Atlantic, leaving the state exposed to significant risks, noted the outlet.
Even the New York Office of Cannabis Management (OCM) cast doubts on the fund&#8217;s viability according to internal OCM documents that questioned whether the deal had overstated the potential revenue and profit potential.
<h1 class="wp-block-heading">What Happened</h1>
New York state, unable to secure a private equity partner, agreed to a $50 million loan from Chicago Atlantic at a 15% interest rate, with all risk borne by the state.
Critics, including Reinvent Albany, an organization that advocates for government transparency and accountability, deemed the deal to have been detrimental to the state and prospective dispensary owners. Legal experts and consultants likened it to distressed debt lending.
Despite the skepticism and advice against the arrangement, negotiations ultimately led to a secret agreement benefiting Chicago Atlantic.
Previously, THE CITY revealed how cannabis licensees who accept loans from the social equity fund are burdened with high construction costs that they don't control and with interest rates that exceed the state's initial estimates.
"Everyone is worried about defaulting because of the rules and regulations of this loan," said Roland Conner, who runs <a href="https://www.benzinga.com/markets/cannabis/23/01/30496199/ny-gov-hochul-announces-opening-of-first-cannabis-shop-owned-by-person-impacted-by-war-on-drugs">Smacked on Bleecker Street</a> in Greenwich Village, the first legal dispensary owned by a person affected by the drug war.
<h1 class="wp-block-heading">Who's Responsible?</h1>
Details of the deal are still secret, with New York state authorities denying Freedom of Information Law requests. The state comptroller&#8217;s office and key lawmakers say they were not informed or involved in the making of the deal, exposing a shocking lack of oversight.
Meanwhile, Chicago Atlantic secured favorable terms, including leasing rights and a $100 million commitment for property development, raising yet more concerns about profiteering at the expense of marginalized communities.
<h1 class="wp-block-heading">Corruption Or Ineptitude?</h1>
The handling of New York&#8217;s cannabis program seems to reflect a corrosive mix of both ineptitude and potential corruption. While officials may have sought to support marginalized groups, their actions suggest a lack of due diligence and transparency.
One element of the story, which you can read in full <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">here</a>, is that social equity applicants are furious.
A Queens shop owner, Dalessio, who was awarded a retail license designated for people impacted by past drug convictions told THE CITY that after a year of back and forth with the fund, he walked away from the deal.
"It just left such a bad taste in my mouth. I warned everyone I could to stay away from this deal," he said.
Photo: Courtesy of Branding Pot via Shutterstock

Government

Legal

Cannabis Saga In The Empire State: Corruption Or Ineptitude? Private Equity Tramples Social Equity, Report Reveals

Alamos Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) reported quarterly Adj earnings of $0.13 per share which met the analyst consensus estimate. The company reported quarterly sales of $277.600 million which beat the analyst consensus estimate of $272.000 million by 2.06 percent. This is a 10.38 percent increase over sales of $251.500 million the same period last year.

Alamos Gold Q1 Adj EPS $0.13, Inline, Sales $277.600M Beat $272.000M Estimate

Piper Sandler analyst Clarke Jeffries maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and maintains $520 price target.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Tyler Technologies, Maintains $520 Price Target

Rogers, who will continue to serve as a director of Mativ and will assume the role of Audit Committee Chair.

Management

MATV

Mativ Holdings Appoints Kimberly Ritrievi As Chair Of Board, Succeeding John Rogers

First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBMS#NASDAQ">FBMS</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 24.42 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $57.341 million which missed the analyst consensus estimate of $59.927 million by 4.32 percent. This is a 11.68 percent decrease over sales of $64.926 million the same period last year.

FBMS

First Bancshares Q1 2024 Adj EPS $0.65 Beats $0.59 Estimate, Sales $57.341M Miss $59.927M Estimate

Guidance

Veris Residential Raises FY24 Core FFO Per Share Outlook From $0.48-$0.53 To $0.50-$0.54, Est $0.53

Colony Bankcorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAN#NASDAQ">CBAN</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.31 by 6.45 percent. This is a 6.45 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $28.141 million which beat the analyst consensus estimate of $27.600 million by 1.96 percent. This is a 0.30 percent decrease over sales of $28.227 million the same period last year.

CBAN

Colony Bankcorp Q1 2024 Adj EPS $0.33 Beats $0.31 Estimate, Sales $28.141M Beat $27.600M Estimate

Needham analyst Mike Matson maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $71 to $82.

Needham Maintains Buy on Boston Scientific, Raises Price Target to $82

CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.34 by 2.94 percent. This is a 16.67 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $126.574 million which beat the analyst consensus estimate of $116.576 million by 8.58 percent. This is a 8.89 percent decrease over sales of $138.930 million the same period last year.

CVBF

CVB Financial Q1 2024 GAAP EPS $0.35 Beats $0.34 Estimate, Sales $126.574M Beat $116.576M Estimate

Bridgewater Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWB#NASDAQ">BWB</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.25 by 4 percent. This is a 35.14 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $26.181 million which missed the analyst consensus estimate of $27.033 million by 3.15 percent. This is a 13.50 percent decrease over sales of $30.267 million the same period last year.

Bridgewater Bancshares Q1 2024 GAAP EPS $0.24 Misses $0.25 Estimate, Sales $26.181M Miss $27.033M Estimate

U.S. President Joe Biden&#8216;s recent signing of legislation has thrown ByteDance&#8217;s TikTok into the spotlight, with CEO Shou Zi Chew saying <a href="https://www.benzinga.com/news/24/03/38001945/amid-us-china-tussle-tiktok-content-creators-worry-about-bread-and-butter-if-app-ban-succeeds">the platform will fight back.</a>
&#8220;Make no mistake, this is a ban, a ban on TikTok and a ban on you and your voice,&#8221; the CEO said in a two-minute&nbsp;<a href="https://www.tiktok.com/@tiktok/video/7361448925972155679" target="_blank" rel="noreferrer noopener">video</a>&nbsp;posted to TikTok&#8217;s main corporate account.
See Also: <a href="https://www.benzinga.com/news/24/04/38372058/analyst-predicts-tiktok-shutdown-in-us-by-next-year-ahead-of-senate-vote-will-not-operate-here">Analyst Predicts TikTok Shutdown In US By Next Year Ahead Of Senate Vote: &#8216;Will Not Operate Here&#8230;&#8217;</a>
Chew&#8217;s statement, delivered Wednesday, April 24, continued: &#8220;Politicians may say otherwise. But don't get confused. Many who sponsored the bill admit a TikTok ban is their ultimate goal.&#8221;
The legislation, part of a $95 million foreign aid package supporting Israel and Ukraine, was widely supported by the U.S. Senate and the House of Representatives.
It gives ByteDance, TikTok&#8217;s parent company, 270 days to find new owners. If ByteDance fails to comply, TikTok faces removal from Apple Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google app stores in the U.S., People magazine <a href="https://people.com/tiktok-ceo-says-we-arent-going-anywhere-biden-signs-potential-ban-into-law-8638226">reported. </a>
Additionally, there&#8217;s a provision for a three-month extension if a sale is in progress by the initial deadline.
<h1 class="wp-block-heading">ByteDance&#8217;s TikTok Fights Back Against Ban</h1>
TikTok&#8217;s uncertain future stems from discussions that began during the COVID-19 pandemic. Former President Donald Trump initially proposed banning the app in April 2020, a move later paused by the Biden administration in February 2021. Currently, TikTok boasts 170 million American users.
The legislation presents concerns about security, with fears that TikTok could be used for Chinese surveillance or data access. TikTok denies these allegations, and the Chinese government asserts there&#8217;s no evidence supporting claims of national security threats. 
TikTok plans to challenge the legislation, citing freedom of speech. In his video, Chew expressed confidence in their legal fight: &#8220;Rest assured, we aren&#8217;t going anywhere.&#8221; 
&#8220;We are confident and we will keep fighting for your rights in the courts&#8230; The facts and the U.S. Constitution are on our side, and we expect to prevail again,&#8221; he added. 
<h1 class="wp-block-heading">Can I Keep Using TikTok? Exploring The Ban&#8217;s Impact</h1>
Don&#8217;t worry, TikTok won&#8217;t just vanish from your phone overnight.
It&#8217;s likely to be at least a year before any ban takes effect, with potential legal challenges possibly extending the timeline further. While TikTok has succeeded in court before, this marks a new challenge against federal legislation.
Concerning your TikTok app, it&#8217;s unlikely to disappear from your phone immediately. However, if the ban goes into effect it may vanish from Apple and Google&#8217;s app stores, meaning no new downloads, updates, or fixes, as <a href="https://www.nbcnewyork.com/news/national-international/tiktok-ban-us-what-to-know/5350848/#:~:text=No%2C%20TikTok%20will%20not%20suddenly%20disappear%20from%20your%20phone.">per</a> NBC New York. 
Over time, this could pose security risks and usability challenges.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38358239/microsoft-and-oracle-could-be-tiktoks-likely-buyers-but-real-winners-would-be-mark-">Microsoft And Oracle Could Be TikTok&#8217;s &#8216;Likely Buyers,&#8217; But Real Winners Would Be Mark Zuckerberg And Sundar Pichai</a>
Photo: <a href="https://www.shutterstock.com/es/g/salarko">salarko</a> on Shutterstock.

Asia

Regulations

Social Media

AAPL

GOOGL

TikTok Fights Back, 'We Aren't Going Anywhere': What's Next For Users?

Barrington Research analyst James Goss maintains Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) with a Outperform and lowers the price target from $14 to $12.

TZOO

Barrington Research Maintains Outperform on Travelzoo, Lowers Price Target to $12

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Grom Social Enterprises&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grom-stock-quote/">GROM</a>) stock is taking a beating on Friday after the company went through <a href="https://finance.yahoo.com/news/grom-social-enterprises-inc-announces-173700954.html">a reverse stock split</a>.
A press release from the media, technology, and entertainment company announced the one-for-20 reverse stock split a couple of days ago. That resulted in it consolidating down 20 shares into a single share when markets opened yesterday.
The reverse stock split initially sent the company&rsquo;s stock falling 28.2% during normal trading hours on Thursday. This came alongside 2.7 million shares changing hands, as compared to a daily average of 78,000 shares.
It looks like that negative movement is going to continue throughout Friday with the stock down 53.3% during pre-market trading. That also comes with more than 468,000 shares of GROM stock having been traded as of this writing.
<h2>More GROM Reverse Stock Split Details</h2>
Grom Social Enterprises notes that after the reverse stock split, there are a total of 452,219 shares of GROM stock outstanding. The company also mentions that warrants to acquire it stock have had their exercise prices adjusted alongside the reverse stock split.
While a reverse stock split doesn&rsquo;t technically affect the market capitalization of a company, that can drop alongside the stock&rsquo;s value. This is because it isn&rsquo;t uncommon to see a company&rsquo;s shares decrease after a reverse stock split goes into effect.
Investors seeking out even more of the most recent stock market news will want to stick around!
We have all of the biggest pre-market stock movers that traders need to know about on Friday! A few examples of that are why shares of AGBA Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) stock and Impel Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/impl-stock-quote/">IMPL</a>) stock are up today, as well as the biggest pre-market stock movers this morning. All of that news is ready to go at the links below!
<h2>More Friday Stock Market News</h2>
<ul>
<li><a href="https://investorplace.com/2023/09/why-is-agba-group-agba-stock-up-32-today/">Why Is AGBA Group (AGBA) Stock Up 32% Today?</a></li>
<li><a href="https://investorplace.com/2023/09/why-is-impel-pharmaceuticals-impl-stock-up-32-today/">Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?</a></li>
<li><a href="https://investorplace.com/2023/09/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-sept-8th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a></li>
</ul>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;
Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT758389">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT758391">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT758395">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/09/why-is-grom-social-enterprises-grom-stock-down-53-today/">Why Is Grom Social Enterprises (GROM) Stock Down 53% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Grom Social Enterprises (GROM) Stock Down 53% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Rosecliff Acquisition&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rclf-stock-quote/">RCLF</a>) stock is falling on Friday after the company provided investors with <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317738276&amp;type=PDF&amp;symbol=RCLFU&amp;cdn=46065817bf97dfa451e0664bfd4268b5&amp;companyName=Rosecliff+Acquisition+Corp+I+Units+consisting+of+one+share+Class+A+common+stock+and+one-third+redeemable+warrants&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-09-07">an update to its SPAC merger plan</a> with Spectral MD.
The biggest news concerning Rosecliff Acquisition is the results from a special meeting of shareholders. These results saw investors in the company vote in favor of the SPAC merger, which is set to take place on or before Sept. 11.
Another bit of news worth noting is an amended rights lock-up agreement. Shareholders voted at the meeting to alter the terms of the Lock-up Period to include all lock-up shares. This also provides updates for when the lock-up period comes to an end.
<h2>How This News Affcets RCLF Stock On Friday</h2>
Following the news from the shareholder meeting, shares of RCLF stock are seeing some 26,000 shares change hands. Investors will note that this is still below the company&rsquo;s daily average trading volume of about 98,000 shares.
It&rsquo;s also worth mentioning that RCLF stock underwent a major rally on Thursday. That saw the stock climb nearly 40% during normal trading hours. This came alongside more than 4.2 million shares of the stock changing hands.
RCLF stock is down 16.8% as of Friday morning and was up 43.6% year-to-date when markets closed on Thursday.
There are even more of the most recent stock market stories worth reading about today below!
Our coverage of the stock market includes all of the biggest stock market news for Friday! That includes everything happening with shares of Grom Social Enterprises&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grom-stock-quote/">GROM</a>), AGBA Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) stock, and Impel Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/impl-stock-quote/">IMPL</a>) stock today. All of that news is ready to go at the following links!
<h2>More Stock Market News For Friday</h2>
<ul>
<li><a href="https://investorplace.com/2023/09/why-is-grom-social-enterprises-grom-stock-down-53-today/">Why Is Grom Social Enterprises (GROM) Stock Down 53% Today?</a></li>
<li><a href="https://investorplace.com/2023/09/why-is-agba-group-agba-stock-up-32-today/">Why Is AGBA Group (AGBA) Stock Up 32% Today?</a></li>
<li><a href="https://investorplace.com/2023/09/why-is-impel-pharmaceuticals-impl-stock-up-32-today/">Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?</a></li>
</ul>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;
Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT758389">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT758391">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT758395">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/09/why-is-rosecliff-acquisition-rclf-stock-down-17-today/">Why Is Rosecliff Acquisition (RCLF) Stock Down 17% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Rosecliff Acquisition (RCLF) Stock Down 17% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We&rsquo;re starting off the workweek right with a breakdown of the biggest pre-market stock movers for Monday!
Moving stocks this morning are clinical trial results, a massive acquisition deal, stock offerings, and more.
Let&rsquo;s get into that news below!

<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Crinetics Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/crnx-stock-quote/">CRNX</a>) stock is rocketing more than 45% following <a href="https://www.nasdaq.com/press-release/crinetics-once-daily-oral-paltusotine-achieved-the-primary-and-all-secondary">positive clinical trial news</a> and <a href="https://www.nasdaq.com/press-release/crinetics-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-18">inducement grants for some new employees</a>.</li>
<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are soaring over 30% alongside heavy pre-market trading.</li>
<li>Aurora Mobile (NASDAQ:<a href="https://investorplace.com/stock-quotes/jg-stock-quote/">JG</a>) stock is surging more than 28% as it also sees <a href="https://www.nasdaq.com/market-activity/stocks/jg/sec-filings">strong early morning trading today</a>.</li>
<li>Hillstream BioPharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/hils-stock-quote/">HILS</a>) shares are rising over 17% <a href="https://www.nasdaq.com/press-release/hillstream-biopharma-to-present-at-h.c.-wainwright-25th-annual-global-investment">ahead of a presentation today</a>.</li>
<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is increasing more than 17% with heavy pre-market trading this morning.</li>
<li>Virax Biolabs (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrax-stock-quote/">VRAX</a>) shares are climbing 16% on Monday morning.</li>
<li>Hostess Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/twnk-stock-quote/">TWNK</a>) stock is gaining over 15% on reports of a <a href="https://www.reuters.com/markets/deals/jm-smucker-nears-deal-buy-twinkies-owner-hostess-brands-wsj-2023-09-11/">$5 billion deal</a> for the company.</li>
<li>Parts iD (NYSEMKT:<a href="https://investorplace.com/stock-quotes/id-stock-quote/">ID</a>) shares are jumping more than 13% despite a lack of news this morning.</li>
<li>Canopy Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) stock is heading over 13% higher after announcing an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317743418&amp;type=PDF&amp;symbol=CGC&amp;cdn=74310dc58f4ffa82c8152651bd6de078&amp;companyName=Canopy+Growth+Corporation&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2023-09-11">updated prospectus for its stock</a>.</li>
<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) shares are up more than 13% on Monday morning.</li>
</ol>
<h2>10 Top Losers</h2>
<ol>
<li>Tenon Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnon-stock-quote/">TNON</a>) stock is plummeting over 39% after announcing a <a href="https://finance.yahoo.com/news/tenon-medical-announces-proposed-public-204000472.html">proposed public stock offering</a>.</li>
<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares are diving more than 15% without any clear news this morning.</li>
<li>Impel Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/impl-stock-quote/">IMPL</a>) stock is tumbling over 15% this morning.</li>
<li>BioCardia (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcda-stock-quote/">BCDA</a>) shares are taking a more than 15% beating on Monday morning.</li>
<li>Akso Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/ahg-stock-quote/">AHG</a>) stock is sliding over 13% without any clear news today.</li>
<li>CourtSide (NASDAQ:<a href="https://investorplace.com/stock-quotes/podc-stock-quote/">PODC</a>) shares are decreasing more than 12% despite a lack of news.</li>
<li>Axcella Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/axla-stock-quote/">AXLA</a>) stock is dropping over 11% following a major rally on Friday.</li>
<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are slipping almost 11% this morning.</li>
<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) stock is dipping more than 9% on Monday morning.</li>
<li>Bullfrog AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfrg-stock-quote/">BFRG</a>) shares close out our pre-market stock movers down over 9%.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT758389">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT758391">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT758395">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/09/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-sept-11th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Moving stocks this morning are a split, clinical trial updates, public offerings and debuts, and more.
Let&rsquo;s get into the latest stock market news below!

<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Novo Nordisk (NYSE:<a href="https://investorplace.com/stock-quotes/nvo-stock-quote/">NVO</a>) stock is rocketing more than 95% after announcing a <a href="https://www.globenewswire.com/news-release/2023/09/13/2742171/0/en/Novo-Nordisk-conducts-a-two-for-one-stock-split.html">two-for-one stock split</a>.</li>
<li>Avalo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/avtx-stock-quote/">AVTX</a>) shares are soaring over 68% after agreeing to <a href="https://www.globenewswire.com/news-release/2023/09/12/2741493/0/en/Avalo-Enters-into-Agreement-to-Divest-AVTX-800-Series.html">sell its rights, title, and assets</a> connected to its 800 Series.</li>
<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) stock is surging more than 22% without any clear news.</li>
<li>Workhorse (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkhs-stock-quote/">WKHS</a>) shares are gaining over 21% after <a href="https://www.benzinga.com/news/23/09/34505985/workhorse-stock-is-surging-after-hours-heres-why">getting IRS approval</a> to be acknowledged as a Commercial Clean Vehicle Credit manufacturer.</li>
<li>Mainz Biomed (NASDAQ:<a href="https://investorplace.com/stock-quotes/mynz-stock-quote/">MYNZ</a>) stock is rising close to 20% alongside <a href="https://www.nasdaq.com/press-release/mainz-biomeds-colofuture-study-evaluating-its-novel-mrna-biomarkers-reports">positive clinical trial results</a> for its cancer treatment.</li>
<li>Rocket Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/rckt-stock-quote/">RCKT</a>) shares are increasing more than 18% <a href="https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-pricing-public-offering-0">despite pricing a public stock offering</a>.</li>
<li>Sigma Lithium (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgml-stock-quote/">SGML</a>) stock is climbing over 16% after <a href="https://www.nasdaq.com/press-release/board-of-directors-receive-proposals-for-sigma-lithium-and-sigma-brazil-from-leading">receiving multiple strategic proposals</a>.</li>
<li>Creative Medical Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/celz-stock-quote/">CELZ</a>) shares are jumping more than 15% on Wednesday morning.</li>
<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reliw-stock-quote/"><a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a></a>) stock is getting an over 13% boost without any clear news today.</li>
<li>Axcella Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/axla-stock-quote/">AXLA</a>) shares are up more than 13% despite a lack of news.</li>
</ol>
<h2>10 Top Losers</h2>
<ol>
<li>Calidi Biotherapeutics (NYSE:<a href="https://investorplace.com/stock-quotes/cldi-stock-quote/">CLDI</a>) stock is plummeting over 36% alongside <a href="https://finance.yahoo.com/news/calidi-biotherapeutics-debuts-publicly-traded-095000662.html">its public debut</a> this morning.</li>
<li>Eiger BioPharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/eigr-stock-quote/">EIGR</a>) shares are crashing more than 34% after <a href="https://finance.yahoo.com/news/eiger-discontinue-phase-3-limt-200500477.html">halting a Phase 3 clinical trial</a>.</li>
<li>Kulr Tech (NYSEMKT:<a href="https://investorplace.com/stock-quotes/kulr-stock-quote/">KULR</a>) stock is diving 29% after <a href="https://www.nasdaq.com/press-release/kulr-announces-pricing-of-%242.5-million-public-offering-of-common-stock-2023-09-13">pricing a public stock offering</a>.</li>
<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are tumbling over 19% without any news to report.</li>
<li>Nature Wood (NASDAQ:<a href="https://investorplace.com/stock-quotes/nwgl-stock-quote/">NWGL</a>) stock is taking a more than 14% beating following its <a href="https://finance.yahoo.com/news/nature-wood-group-limited-announces-044400642.html">public debut yesterday</a>.</li>
<li>Evolution Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/epm-stock-quote/">EPM</a>) shares are heading nearly 14% lower following its <a href="https://www.nasdaq.com/press-release/evolution-petroleum-reports-full-year-and-fourth-quarter-fiscal-2023-results-and">latest earnings report</a>.</li>
<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) stock is sliding over 13% on Wednesday morning.</li>
<li>Genetic Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/gene-stock-quote/">GENE</a>) shares are dropping more than 12% today.</li>
<li>Impel Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/impl-stock-quote/">IMPL</a>) stock is decreasing over 12% today.</li>
<li>OKYO Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/okyo-stock-quote/">OKYO</a>) shares close out our pre-market stock movers down almost 12%.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT758392">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT758390">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT758396">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/09/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-sept-13th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

In a report released today, Sean Kim PhD from JonesTrading maintained a Hold rating on Impel Pharmaceuticals (IMPL – Research Report). The company'...

Impel Pharmaceuticals (IMPL) Receives a Hold from JonesTrading

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Impel Pharmaceuticals (IMPL – Research Report) and...

Analysts Offer Insights on Healthcare Companies: Impel Pharmaceuticals (IMPL) and Relay Therapeutics (RLAY)

The market has been high on Impel Pharmaceuticals Inc (IMPL)  stock recently. IMPL gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Impel Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMPL!See Full IMPL ReportWhat is Stock Sen

What is the Market's View on Impel Pharmaceuticals Inc (IMPL) Stock's Price and Volume Trends Friday?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning!



Moving stocks this morning are business updates, upcoming conferences and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Near Intelligence (NASDAQ:<a href="https://investorplace.com/stock-quotes/nir-stock-quote/">NIR</a>) stock is rocketing close to 72% alongside heavy pre-market trading.</li>



<li>Nyxoah (NASDAQ:<a href="https://investorplace.com/stock-quotes/nyxh-stock-quote/">NYXH</a>) shares are soaring more than 59% as it <a href="https://www.nasdaq.com/press-release/nyxoah-to-participate-in-the-piper-sandler-35th-annual-healthcare-conference-2023-0">prepares to take part</a> in the Piper Sandler 35th Annual Healthcare Conference this week.</li>



<li>Mobiquity Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/mobq-stock-quote/">MOBQ</a>) stock is surging nearly 56% with strong early morning trading.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) shares are gaining over 25% as they see heavy pre-market trading this morning.</li>



<li>Apollomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aplm-stock-quote/">APLM</a>) stock is increasing more than 24% with strong Monday morning trading activity.</li>



<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares are rising almost 24% on heavy trading today.</li>



<li>Perfect (NYSE:<a href="https://investorplace.com/stock-quotes/perf-stock-quote/">PERF</a>) stock is climbing over 19% after launching a <a href="https://www.nasdaq.com/press-release/perfect-corp.-announces-commencement-of-self-tender-offer-to-purchase-up-to-16129032">self-tender offer</a>.</li>



<li>Avenue Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/atxi-stock-quote/">ATXI</a>) shares are getting a 17% boost despite a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317888137&amp;type=PDF&amp;symbol=ATXI&amp;cdn=c5b2b7f469445c9a3d7e0a7515ed419b&amp;companyName=Avenue+Therapeutics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-11-24">recent delisting notice</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is jumping more than 14% without any news to report this morning.</li>



<li>Theseus Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/thrx-stock-quote/">THRX</a>) shares are up over 12% after getting an <a href="https://www.nasdaq.com/press-release/theseus-pharmaceuticals-confirms-receipt-of-unsolicited-expression-of-interest-from">unsolicited expression of interest</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Impel Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/impl-stock-quote/">IMPL</a>) stock is diving close to 21% on Monday morning.</li>



<li>Hitek Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/hkit-stock-quote/">HKIT</a>) shares are tumbling more than 18% without any obvious news.</li>



<li>AgriForce Growing Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) stock is taking an over 17% beating alongside a <a href="https://www.nasdaq.com/press-release/agriforce-ceo-provides-letter-to-shareholders-2023-11-22">letter from the CEO to shareholders</a>.</li>



<li>Telesis Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/tbio-stock-quote/">TBIO</a>) shares are sliding more than 17% without any clear news to report.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) stock is decreasing over 16% on Monday morning.</li>



<li>BioNexus Gene Lab (NASDAQ:<a href="https://investorplace.com/stock-quotes/bglc-stock-quote/">BGLC</a>) shares are dropping more than 15% this morning.</li>



<li>Edesa Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/edsa-stock-quote/">EDSA</a>) stock is falling over 13% today.</li>



<li>Addentax (NASDAQ:<a href="https://investorplace.com/stock-quotes/atxg-stock-quote/">ATXG</a>) shares are slipping more than 13% on Monday.</li>



<li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is dipping over 12% this morning.</li>



<li>Altamira Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyto-stock-quote/">CYTO</a>) shares close out our pre-market stock movers down more than 11% after getting <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317886583&amp;type=PDF&amp;symbol=CYTO&amp;cdn=48613696dce0c615b2d5085a1e351115&amp;companyName=Altamira+Therapeutics+Ltd.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2023-11-22">a recent delisting notice</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT766529">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/11/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-nov-27th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Impel Pharmaceuticals Inc (IMPL) is around the top of the Biotechnology industry according to InvestorsObserver. IMPL received an overall rating of 80, which means that it scores higher than 80 percent of all stocks. Impel Pharmaceuticals Inc also achieved a score of 95 in the Biotechnology industry, putting it above 95 pe

Should Biotechnology Stock Impel Pharmaceuticals Inc (IMPL) Be in Your Portfolio Monday?

Impel files for voluntary chapter 11, signs "stalking horse" agreement to facilitate sale

AGBA

ATXG

AVTX

AXLA

BCDA

BFRG

CELZ

CLDI

CRNX

CYTO

EDSA

EIGR

GENE

GNLN

GROM

HILS

KULR

MESO

MIRA

MYNZ

NUWE

NWGL

NYXH

OKYO

PERF

PODC

RCKT

RCLF

RELI

RLAY

SGML

TBIO

THRX

TNON

TWNK

VRAX

WKHS

WLGS

WRNT

ZAPP

Health Care

Press Releases

Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

Opinion

Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals?

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale

CINC

GOEV

PLUG